Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: A nested case-control study using IgG titer against Hp surface antigen

References

• Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784–9
   PubMed Web of Science ®Google Scholar
• Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 2006; 98: 1445–52
   PubMed Web of Science ®Google Scholar
• Group HaCC. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347–53.
   PubMed Web of Science ®Google Scholar
• Vauhkonen M, Vauhkonen H, Sipponen P. Pathology and molecular biology of gastric cancer. Best Pract Res Clin Gastroenterol 2006; 20: 651–74
   PubMed Web of Science ®Google Scholar
• Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114: 1169–79
   PubMed Web of Science ®Google Scholar
• Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: A meta-analysis. Am J Gastroenterol 1999; 94: 2373–9
   PubMed Web of Science ®Google Scholar
• Sasazuki S, Inoue M, Iwasaki M, Otani T, Yamamoto S, Ikeda S, et al. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: A nested case-control study. Cancer Epidemiol Biomarkers Prev 2006; 15: 1341–7
   PubMed Web of Science ®Google Scholar
• Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furihata C, et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987; 22: 133–41
   PubMedGoogle Scholar
• Dinis-Ribeiro M, Yamaki G, Miki K, Costa-Pereira A, Matsukawa M, Kurihara M. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 2004; 11: 141–7
   PubMed Web of Science ®Google Scholar
• Marchildon P, Balaban DH, Sue M, Charles C, Doobay R, Passaretti N, et al. Usefulness of serological IgG antibody determinations for confirming eradication of Helicobacter pylori infection. Am J Gastroenterol 1999; 94: 2105–8
   PubMed Web of Science ®Google Scholar
• Nishizono A, Gotoh T, Fujioka T, Murakami K, Kubota T, Nasu M, et al. Serological assessment of the early response to eradication therapy using an immunodominant outer membrane protein of Helicobacter pylori. Clin Diagn Lab Immunol 1998; 5: 856–61
   PubMedGoogle Scholar
• Koizumi W, Tanabe S, Imaizumi H, Hibi K, Kida M, Ohida M, et al. Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection. Hepatogastroenterology 2003; 50: 293–6
   PubMedGoogle Scholar
• Zagari RM, Pozzato P, Martuzzi C, Fuccio L, Martinelli G, Roda E, et al. 13C-urea breath test to assess Helicobacter pylori bacterial load. Helicobacter 2005; 10: 615–9
   PubMed Web of Science ®Google Scholar
• WHO International classification of diseases for oncology. 2nd ed. Geneva: WHO; 1990.
   Google Scholar
• Japanese Research Society for Gastric Cancer. The general rules for gastric cancer study. 12th ed. Tokyo: Kanehara; 1993.
   Google Scholar
• Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. APMIS 1965; 64: 31–49
   Web of Science ®Google Scholar
• Karnes WE, Jr, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim SW, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991; 101: 167–74
   PubMed Web of Science ®Google Scholar
• Tatemichi M, Kabuto M, Tsugane S. Effect of smoking on serum pepsinogen I level depends on serological status of Helicobacter pylori. Jpn J Cancer Res 2001; 92: 243–8
   PubMedGoogle Scholar
• Fujishiro M, Oka M, Yahagi N, Nakamura M, Kakushima N, Kodashima S, et al. Correlation of serum pepsinogens and gross appearances combined with histology in early gastric cancer. J Exp Clin Cancer Res 2006; 25: 207–12
   PubMed Web of Science ®Google Scholar
• Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004; 53: 1082–9
   PubMed Web of Science ®Google Scholar
• El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398–402
   PubMed Web of Science ®Google Scholar
• Togawa S, Joh T, Itoh M, Katsuda N, Ito H, Matsuo K, et al. Interleukin-2 gene polymorphisms associated with increased risk of gastric atrophy from Helicobacter pylori infection. Helicobacter 2005; 10: 172–8
   PubMed Web of Science ®Google Scholar
• Taguchi A, Ohmiya N, Shirai K, Mabuchi N, Itoh A, Hirooka Y, et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 2005; 14: 2487–93
   PubMed Web of Science ®Google Scholar
• Li C, Xia B, Yang Y, Li J, Xia HH. TNF gene polymorphisms and Helicobacter pylori infection in gastric carcinogenesis in Chinese population. Am J Gastroenterol 2005; 100: 290–4
   PubMed Web of Science ®Google Scholar
• Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003; 125: 364–71
   PubMed Web of Science ®Google Scholar
• Macarthur M, Hold GL, El-Omar EM. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 2004; 286: G515–G520
   PubMed Web of Science ®Google Scholar
• van den Engel NK, Winter H, Ruttinger D, Shau I, Schiller M, Mayer B, et al. Characterization of immune responses in gastric cancer patients: A possible impact of H. pylori to polarize a tumor-specific type 1 response?. Clin Immunol 2006; 120: 285–96
   PubMed Web of Science ®Google Scholar
• Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 2003; 125: 1636–44
   PubMed Web of Science ®Google Scholar
• Tatemichi M, Hamada GS, Nishimoto IN, Kowalski LP, Iriya K, Rodrigues JJ, et al. Ethnic difference in serology of Helicobacter pylori CagA between Japanese and non-Japanese Brazilians for non-cardia gastric cancer. Cancer Sci 2003; 94: 64–9
   PubMed Web of Science ®Google Scholar
• Fujioka T, Tokieda M. Validity of serum anti-Helicobacter pylori antibody using enzyme immunoassay for the diagnosis in eradication of Helicobacter pylori. Jpn J Med Pharm Sci 2000; 43: 573–9
   Google Scholar
• Iwasaki M, Otani T, Yamamoto S, Inoue M, Hanaoka T, Sobue T, et al. Background characteristics of basic health examination participants: The JPHC Study Baseline Survey. J Epidemiol 2003; 13: 216–25
   PubMed Web of Science ®Google Scholar